Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 15Carcinoma, Hepatocellular 8Neoplasm Metastasis 3Rectal Neoplasms 2Melanoma 2Cholangiocarcinoma 2Advanced Colorectal Cancer 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Tertiary Lymphoid Structures 1TAS 102 1Stomach Neoplasms 1Sarcoma 1Mesothelioma, Malignant 1Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Fatigue 1Colorectal Cancer Metastatic 1Colorectal Cancer Liver Metastases 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Biliary Tract Neoplasms 1Asian Colorectal Cancer Patients 1Advanced Colorectal Carcinoma 1Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy 1

Interventions

surufatinib 2regorafenib 2Oxaliplatin 2Irinotecan 2Fluorouracil 2Drug Therapy 2Bevacizumab 2raltitrexed 1nimotuzumab 1endostar protein 1aflibercept 1Folfox protocol 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Advanced Colorectal Cancer × regorafenib × Clear all
NCT06200363 2024-01-11

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

West China Hospital

Phase 1 Unknown
15 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT02619435 2023-03-24

STREAM

National Cancer Institute, Naples

Phase 2 Unknown
46 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡